Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction-Reference-Cited by-同舟云学术

Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction

Published:2024-03-07 Issue:4 Volume:40 Page:921-930
ISSN:1875-8312
Container-title:The International Journal of Cardiovascular Imaging
language:en
Short-container-title:Int J Cardiovasc Imaging

Author:

Zhong Ying,Li Ce,Yu Yang,Du Yaqi,Bai Yun,Wang Xinrui,Dai Xu,Fan Guoguang,Wang Guan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10554-024-03061-7.pdf

Reference31 articles.

1. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice guidelines. Circulation 124:2761–2796. https://doi.org/10.1161/CIR.0b013e318223e230

2. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE et al (2003) A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24:1965–1991. https://doi.org/10.1016/s0195-668x(03)00479-2

3. O’Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56:867–874. https://doi.org/10.1016/j.jacc.2010.05.010

4. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T et al (2014) Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation 130:484–495. https://doi.org/10.1161/CIRCULATIONAHA

5. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56:875–887. https://doi.org/10.1016/j.jacc.2010.05.007